Moebius Analytics
AI predictive analytics API for anesthesiology risk assessment and perioperative care, sold to healthcare software vendors
Highlights
- Young companyFounded 2022
- New on EvolcAdded 2026-11-02
About Moebius Analytics
Moebius Analytics builds a SaaS API that provides real-time health monitoring and dynamic surgical risk assessment through an adaptive questionnaire, combined with certified smartwatch monitoring for patients.
Its customers are healthcare software vendors and hospitals, which integrate the API into their systems; the company is natively integrated with Diane Anesthesia by BowMedical.
The company was founded on 20 December 2022 and is headquartered in Bron, France, where it is registered as a SAS. It states that it is expanding to the USA.
Product: SaaS API for predictive risk assessment and perioperative optimisation in anesthesiology, with an intelligent questionnaire and smartwatch monitoring.
Jobs at Moebius Analytics
More health & medtech companies
Moka.Care
Mental health prevention platform and services for employers' staff, managers and HR teams in FranceNew on EvolcMonecho
Ultrasound reporting software that automates report writing for gynaecology, cardiology and general ultrasound practices in FranceNew on EvolcMove In Med
Care pathway design and the UniQ coordination platform for healthcare facilities, health networks and professionals in FranceNew on EvolcMultiwave Technologies
Develops portable ultra-low-field MRI scanners for hospitals, researchers and care providersNew on EvolcMycareprocess
Real-time care-progress app that keeps emergency patients and their relatives informed, for French hospital emergency departmentsYoung companyNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Frontend frameworks
- jQueryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.